Urology & Nephrology News, Treatment Studies | Renal, Urology …
Medical virtual assistants typically are remote workers who can handle social media accounts and administrative tasks such as appointment scheduling and insurance verifications, and billing.
News Archive - Renal and Urology News
Jan 24, 2025 · A systematic review and meta-analysis explored the relationship between androgen deprivation therapy and risk for heart failure in men with prostate cancer who were …
Ta Low-Grade NMIBC Recurrence Not Uncommon After 5 Years
5 days ago · References: Villegas E, Lajkosz K, Din S, et al. Long-term recurrence risk, metastatic potential, and length of cystoscopic surveillance of low-grade non-muscle-invasive bladder …
GLP-1 Receptor Agonists May Have Broader Range of Benefits, Risks
Jan 24, 2025 · References: Xie Y, Choi T, Al-Aly Z. Mapping the effectiveness and risks of GLP-1 receptor agonists. Nat Med.Published online January 20, 2025. doi:10.1038/s41591-024 ...
Node-Positive UTUC Management Should Include Radical Surgery
6 days ago · Among management options for node-positive upper tract urothelial cancer (UTUC), induction chemotherapy added to radical nephroureterectomy (RNU) provides the best cancer …
Panel Issues New Guidelines for Advanced Prostate Cancer
Jan 13, 2025 · Managing advanced prostate cancer is increasingly complex, with some aspects lacking sufficient level 1 evidence. To address some of the more pressing issues, the 2024 US …
Finerenone Increases Hyperkalemia Risk in Patients With Mild …
Jan 17, 2025 · References: Vardeny O, Vaduganathan M, Claggett BL, et al. Finerenone, serum potassium, and clinical outcomes in heart failure with mildly reduced or preserved ejection …
Lumasiran Shows Long-Term Efficacy in Primary Hyperoxaluria …
Oct 29, 2024 · Final results from the phase 3 ILLUMINATE-A trial confirm the clinical benefit of long-term lumasiran treatment in patients with primary hyperoxaluria type 1 (PH1), according …
Only One-Third of Men Receive First-Line mCSPC Treatment ...
Dec 18, 2024 · References: Agarwal N, George DJ, Klaassen Z, et al. Physician reasons for or against treatment intensification in patients with metastatic prostate cancer. JAMA Netw Open. …
Empagliflozin Carryover Effect Found in Patients With Chronic …
Oct 25, 2024 · Empagliflozin continues to provide cardiorenal benefit in patients with chronic kidney disease (CKD) for up to 12 months after it is discontinued, William G. Herrington, …